1,000 units of marijuana medicine sent to US-based trial in a clinical setting

Any/all of the links on this website are affiliate links of which we receive a small commission from the sale of certain items, but the price remains the same for you.

Over the course of the last few months, a pharmaceutical giant MGC Pharma (ASX:MXC) has stated out loud that a $24 million supply of cannabis based products partnered with AMC Holdings (a pharna comp. unrelated to the king pin) will be available.

View the rest of the story here: https://www.ponderingpot.com.au/national/mgc-pharma-asx-mxc-to-send-1000-units-of-cannabis-medicine-to-us-based-clinical-trial/

Related Posts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.